{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:16:16Z","timestamp":1792725376526,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK107806"],"award-info":[{"award-number":["R01DK107806"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21\/R33AI079740"],"award-info":[{"award-number":["R21\/R33AI079740"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AI113127"],"award-info":[{"award-number":["U19AI113127"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004349","name":"BASF","doi-asserted-by":"publisher","award":["F127"],"award-info":[{"award-number":["F127"]}],"id":[{"id":"10.13039\/100004349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004349","name":"BASF","doi-asserted-by":"publisher","award":["P30EY001765"],"award-info":[{"award-number":["P30EY001765"]}],"id":[{"id":"10.13039\/100004349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004349","name":"BASF","doi-asserted-by":"publisher","award":["UL1 TR001079"],"award-info":[{"award-number":["UL1 TR001079"]}],"id":[{"id":"10.13039\/100004349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.biomaterials.2018.09.005","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T20:48:32Z","timestamp":1536266912000},"page":"97-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":110,"special_numbering":"C","title":["Mucus-penetrating budesonide nanosuspension enema for local treatment of inflammatory bowel disease"],"prefix":"10.1016","volume":"185","author":[{"given":"Abhijit A.","family":"Date","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilad","family":"Halpert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taarika","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jairo","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranjali","family":"Kanvinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Dimitrion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janani","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Zierden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpana","family":"Betageri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Musmanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron A.","family":"Wiegand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinglu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Gumber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Hanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Ensign","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biomaterials.2018.09.005_bib1","first-page":"405","article-title":"Immunopathogenesis of inflammatory bowel disease","volume":"26","author":"Matricon","year":"2010","journal-title":"M S-Med. Sci."},{"issue":"2","key":"10.1016\/j.biomaterials.2018.09.005_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/gut.41.2.209","article-title":"Oral budesonide is as effective as oral prednisolone in active Crohn's disease","volume":"41","author":"Campieri","year":"1997","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.biomaterials.2018.09.005_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/2040622310379293","article-title":"Therapeutic benefits of budesonide in gastroenterology","volume":"1","author":"O'Donnell","year":"2010","journal-title":"Therapeut. Adv. Chron. Dis."},{"issue":"5","key":"10.1016\/j.biomaterials.2018.09.005_bib4","first-page":"309","article-title":"Advantages in IBD: current developments in the treatment of inflammatory bowel diseases","volume":"6","author":"Cohen","year":"2010","journal-title":"Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.biomaterials.2018.09.005_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1586\/ecp.12.2","article-title":"Mesalamine in the treatment and maintenance of remission of ulcerative colitis","volume":"5","author":"Ham","year":"2012","journal-title":"Expet Rev. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.biomaterials.2018.09.005_bib6","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1053\/j.gastro.2015.01.037","article-title":"Budesonide foam induces remission in patients with mild to moderate ulcerative proctitis and ulcerative proctosigmoiditis","volume":"148","author":"Sandborn","year":"2015","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.biomaterials.2018.09.005_bib7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0016-5085(98)70131-3","article-title":"Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study group","volume":"115","author":"Hanauer","year":"1998","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.biomaterials.2018.09.005_bib8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","article-title":"Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers","volume":"64","author":"Ensign","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2018.09.005_bib9","first-page":"48","article-title":"Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse","volume":"197C","author":"Maisel","year":"2014","journal-title":"J. Contr. Release offic. J. Contr. Release Soc."},{"issue":"4","key":"10.1016\/j.biomaterials.2018.09.005_bib10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF00226330","article-title":"Rectal pharmacokinetics of budesonide","volume":"49","author":"Dahlstrom","year":"1996","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.biomaterials.2018.09.005_bib11","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1046\/j.1365-2036.1997.00199.x","article-title":"Colonic spread of 5-ASA enemas in healthy individuals, with a comparison of their physical and chemical characteristics","volume":"11","author":"Otten","year":"1997","journal-title":"Aliment Pharmacol. Therapeut."},{"issue":"6","key":"10.1016\/j.biomaterials.2018.09.005_bib12","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1021\/mp400087y","article-title":"Ex vivo characterization of particle transport in mucus secretions coating freshly excised mucosal tissues","volume":"10","author":"Ensign","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2018.09.005_bib13","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jconrel.2015.04.040","article-title":"Enema ion compositions for enhancing colorectal drug delivery","volume":"209","author":"Maisel","year":"2015","journal-title":"J. Contr. Release : offic. J. Contr. Release Soc."},{"issue":"138","key":"10.1016\/j.biomaterials.2018.09.005_bib14","doi-asserted-by":"crossref","first-page":"138ra79","DOI":"10.1126\/scitranslmed.3003453","article-title":"Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus","volume":"4","author":"Ensign","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"28","key":"10.1016\/j.biomaterials.2018.09.005_bib15","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.1016\/j.biomaterials.2013.05.039","article-title":"Enhanced vaginal drug delivery through the use of hypotonic formulations that induce fluid uptake","volume":"34","author":"Ensign","year":"2013","journal-title":"Biomaterials"},{"issue":"20","key":"10.1016\/j.biomaterials.2018.09.005_bib16","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.3748\/wjg.v16.i20.2537","article-title":"Anti-inflammatory efficiency of levobupivacaine in an experimental colitis model","volume":"16","author":"Duman","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biomaterials.2018.09.005_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jconrel.2014.03.039","article-title":"Budesonide loaded nanoparticles with pH-sensitive coating for improved mucosal targeting in mouse models of inflammatory bowel diseases","volume":"183","author":"Ali","year":"2014","journal-title":"J. Contr. Release : offic. J. Contr. Release Soc."},{"issue":"11","key":"10.1016\/j.biomaterials.2018.09.005_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050388","article-title":"Temporal colonic gene expression profiling in the recurrent colitis model identifies early and chronic inflammatory processes","volume":"7","author":"Kremer","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biomaterials.2018.09.005_bib19","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nprot.2007.41","article-title":"Chemically induced mouse models of intestinal inflammation","volume":"2","author":"Wirtz","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biomaterials.2018.09.005_bib20","article-title":"Isolation and characterization of dendritic cells and macrophages from the mouse intestine","volume":"63","author":"Geem","year":"2012","journal-title":"J. Vis. Exp."},{"issue":"6","key":"10.1016\/j.biomaterials.2018.09.005_bib21","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.immuni.2012.08.026","article-title":"Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells","volume":"37","author":"Zigmond","year":"2012","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.biomaterials.2018.09.005_bib22","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1002\/anie.201006849","article-title":"Biodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus","volume":"50","author":"Yang","year":"2011","journal-title":"Angew. Chem."},{"issue":"21","key":"10.1016\/j.biomaterials.2018.09.005_bib23","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1002\/adhm.201600599","article-title":"Mucus-penetrating nanosuspensions for enhanced delivery of poorly soluble drugs to mucosal surfaces","volume":"5","author":"Yu","year":"2016","journal-title":"Adv. Healthc. Mater."},{"issue":"3","key":"10.1016\/j.biomaterials.2018.09.005_bib24","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.crohns.2013.08.007","article-title":"Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: rapid symptom resolution and improvements in quality of life","volume":"8","author":"Probert","year":"2014","journal-title":"J. Crohn's Colitis"},{"issue":"5","key":"10.1016\/j.biomaterials.2018.09.005_bib25","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.nano.2015.02.018","article-title":"Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue","volume":"11","author":"Hua","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"9","key":"10.1016\/j.biomaterials.2018.09.005_bib26","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1007\/s11434-016-1056-4","article-title":"Nanoparticle-based oral delivery systems for colon targeting: principles and design strategies","volume":"61","author":"Lu","year":"2016","journal-title":"Sci. Bull."},{"issue":"2","key":"10.1016\/j.biomaterials.2018.09.005_bib27","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jconrel.2008.05.022","article-title":"An in vivo comparison of intestinal pH and bacteria as physiological trigger mechanisms for colonic targeting in man","volume":"130","author":"McConnell","year":"2008","journal-title":"J. Contr. Release : offic. J. Contr. Release Soc."},{"issue":"8","key":"10.1016\/j.biomaterials.2018.09.005_bib28","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1007\/s11095-008-9580-9","article-title":"Interplay between intestinal pH, transit time and feed status on the in vivo performance of pH responsive ileo-colonic release systems","volume":"25","author":"Ibekwe","year":"2008","journal-title":"Pharm. Res. Dordr."},{"issue":"4","key":"10.1016\/j.biomaterials.2018.09.005_bib29","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/gut.48.4.571","article-title":"Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs","volume":"48","author":"Nugent","year":"2001","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.biomaterials.2018.09.005_bib30","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.ijpharm.2013.05.017","article-title":"Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis","volume":"454","author":"Beloqui","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2018.09.005_bib31","first-page":"3789","article-title":"Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy","volume":"9","author":"Naeem","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"issue":"9","key":"10.1016\/j.biomaterials.2018.09.005_bib32","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrd1494","article-title":"Nanosuspensions in drug delivery, Nature reviews","volume":"3","author":"Rabinow","year":"2004","journal-title":"Drug Discov."},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2018.09.005_bib33","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijpharm.2009.07.005","article-title":"A comparative study of top-down and bottom-up approaches for the preparation of micro\/nanosuspensions","volume":"380","author":"Verma","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.biomaterials.2018.09.005_bib34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11095-012-0889-z","article-title":"Application of drug nanocrystal technologies on oral drug delivery of poorly soluble drugs","volume":"30","author":"Gao","year":"2013","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.biomaterials.2018.09.005_bib35","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1023\/A:1014276917363","article-title":"Production and characterization of a budesonide nanosuspension for pulmonary administration","volume":"19","author":"Jacobs","year":"2002","journal-title":"Pharm Res"},{"issue":"11","key":"10.1016\/j.biomaterials.2018.09.005_bib36","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1002\/jps.21380","article-title":"Fluticasone and budesonide nanosuspensions for pulmonary delivery: preparation, characterization, and pharmacokinetic studies","volume":"97","author":"Yang","year":"2008","journal-title":"J. Pharmaceut. Sci."},{"issue":"2","key":"10.1016\/j.biomaterials.2018.09.005_bib37","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1517\/17425247.2016.1114604","article-title":"Size-dependent nanoparticulate drug delivery in inflammatory bowel diseases","volume":"13","author":"Youshia","year":"2016","journal-title":"Expet Opin. Drug Deliv."},{"issue":"4","key":"10.1016\/j.biomaterials.2018.09.005_bib38","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1053\/j.gastro.2012.06.043","article-title":"An orally administered redox nanoparticle that accumulates in the colonic mucosa and reduces colitis in mice","volume":"143","author":"Vong","year":"2012","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.biomaterials.2018.09.005_bib39","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1023\/A:1011032328064","article-title":"Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa","volume":"18","author":"Lamprecht","year":"2001","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.biomaterials.2018.09.005_bib40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jconrel.2012.10.019","article-title":"Nano- and microscaled particles for drug targeting to inflamed intestinal mucosa: a first in vivo study in human patients","volume":"165","author":"Schmidt","year":"2013","journal-title":"J. Contr. Release : offic. J. Contr. Release Soc."},{"issue":"3 Pt A","key":"10.1016\/j.biomaterials.2018.09.005_bib41","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ejpb.2013.09.016","article-title":"PEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease","volume":"85","author":"Lautenschlager","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"5","key":"10.1016\/j.biomaterials.2018.09.005_bib42","doi-asserted-by":"crossref","first-page":"G922","DOI":"10.1152\/ajpgi.2001.280.5.G922","article-title":"The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo","volume":"280","author":"Atuma","year":"2001","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"5","key":"10.1016\/j.biomaterials.2018.09.005_bib43","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s11095-015-1852-6","article-title":"Budesonide loaded PLGA nanoparticles for targeting the inflamed intestinal mucosa--pharmaceutical characterization and fluorescence imaging","volume":"33","author":"Ali","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biomaterials.2018.09.005_bib44","series-title":"Induction of TNBS Colitis in Mice, Current Protocols in Immunology","author":"Scheiffele","year":"2002"},{"issue":"16","key":"10.1016\/j.biomaterials.2018.09.005_bib45","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids--new mechanisms for old drugs","volume":"353","author":"Rhen","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.biomaterials.2018.09.005_bib46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.tem.2012.11.005","article-title":"The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and restore","volume":"24","author":"Busillo","year":"2013","journal-title":"Trends Endocrinol. Metabol."},{"issue":"2\u20133","key":"10.1016\/j.biomaterials.2018.09.005_bib47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jsbmb.2010.03.058","article-title":"The role of the glucocorticoid receptor in inflammation and immunity","volume":"120","author":"Baschant","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"7","key":"10.1016\/j.biomaterials.2018.09.005_bib48","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ncpgasthep0528","article-title":"Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis","volume":"3","author":"Sartor","year":"2006","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.biomaterials.2018.09.005_bib49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/gut.52.1.65","article-title":"Increased expression of interleukin 17 in inflammatory bowel disease","volume":"52","author":"Fujino","year":"2003","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.biomaterials.2018.09.005_bib50","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1084\/jem.194.9.1207","article-title":"Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide","volume":"194","author":"Krieglstein","year":"2001","journal-title":"J. Exp. Med."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961218306367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961218306367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T14:33:20Z","timestamp":1736519600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961218306367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":50,"alternative-id":["S0142961218306367"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2018.09.005","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucus-penetrating budesonide nanosuspension enema for local treatment of inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2018.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}